Mr Tony Tan is the Non-Executive Chairman of SMG and is responsible for providing leadership to the Board of Directors of the Group and overall strategic guidance. Mr Tan is also a Non-Independent Non-Executive Director of IGB Corporation Bhd since 15 July 2003. Mr Tan has vast experience in the healthcare industry. He was the founder and Managing Director of Parkway Holdings Limited, Singapore until 2000 and Deputy Chairman until his retirement in 2005. During his service, he initiated acquisitions and developments by Parkway Holdings Limited both in Singapore and overseas to build its healthcare franchise from initially a property developer to one of the largest private healthcare providers in Asia. He holds a Bachelor of Chemical Engineering from the University of Surrey, England and a Master’s in Business Administration from the University of California, Berkeley, United States.
Dr Beng has been CEO and Executive Director of SMG since 2013. He previously led multi-billion dollar businesses and large teams in the information technology and healthcare sectors across Asia Pacific and Japan over the last decade as a senior manager in multinational corporations like Hewlett Packard (HP) and General Electric (GE). Dr Beng started his professional career as a Medical Officer with the Singapore Ministry of Health after graduating from the University of Manchester Medical School in the United Kingdom. He also holds a Master’s in Business Administration from the Booth School of Business, University of Chicago and is an alumnus of Harvard Business School.
Mr Ho Lon Gee is an Independent Director of the SMG’s Board and Chairman of the Audit Committee since June 2009. Mr Ho is currently the Chief Executive Officer of Tricor Singapore Pte Ltd, where he oversees the management of Tricor group of companies in Singapore. From 1982 to 2004, he was an Auditor and Partner at PricewaterhouseCoopers Singapore where he headed the SME Enterprise Audit Group and the Corporate Services Practice. Mr Ho is a qualified Chartered Accountant with the Institute of Chartered Accountants in England and Wales. He is also a member of the Institute of Singapore Chartered Accounts and the Singapore Institute of Directors. In addition, Mr Ho also serves as Honorary Treasurer to the Singapore Children’s Society as well as Chairman of its Investment Committee and a member of its Remuneration Committee.
Mr Jimmy Yim is an independent Director and chairs the Nominating and Remuneration Committees. He has been a member of the Board of SMG since June 2009. Mr Yim is the Chairman and simultaneously the Managing Director of the Dispute Resolution practice of Drew and Napier LLC, a leading all-service legal practice in Singapore, established in 1889. He was admitted to the Singapore Bar in 1983 and is one of the earliest batch of Senior Counsel being appointed in January 1998. His practice covers a wide range of civil and commercial law, corporate law and international commercial arbitrations. Amongst his several appointments include being Fellow of the Singapore Institute of Arbitrators and Regional Arbitrator with the Singapore International Arbitration Centre (SIAC). Apart from SMG, Mr Yim also sits on the board of Low Keng Huat (Singapore) Limited. He is recommended by name in various professional journals and ranking agencies in the area of dispute resolution and construction law.
Ms Stefanie Yuen Thio is the Joint Managing Partner of TSMP Law Corporation and heads its corporate practice. She was admitted to the Singapore Bar in 1994 and her areas of expertise include mergers and acquisitions, equity capital markets, corporate transactions and regulatory advice. She is regularly named by legal journals as a leading practitioner in her areas of specialisation.
Ms Thio was appointed by the Monetary Authority of Singapore to the Corporate Governance Council 2017 to review the Code of Corporate Governance and is a Fellow of the Singapore Institute of Directors. From 2014 to 2017, she was a member of the Expert Panel, Centre for Cross-Border Commercial Law in Asia. She was also a member of the Singapore Governance and Transparency Index (“SGTI”) Advisory Panel from June 2016 to May 2018. Apart from SMG, Ms Thio also sits on the board of ESR Funds Management (S) Limited which manages ESR-REIT.
Dr Wong Seng Weng is currently the Medical Director and Consultant Medical Oncologist of The Cancer Centre at SMG. He holds the appointments of Executive Director of the Board of Directors and Chairman of the Medical Board of SMG. Dr Wong obtained his basic medical degree from the National University of Singapore (NUS) under the Lim Boon Keng and Tan Siak Kew Scholarships and graduated on the Dean’s List of outstanding academic achievement. He completed his post-graduate training in Internal Medicine and obtained his Membership of the Royal College of Physicians of the United Kingdom (MRCP UK). Thereafter, he achieved Specialist Accreditation with the Ministry of Health Singapore and was admitted as Fellow of the Academy of Medicine of Singapore (FAMS) and College of Physicians of Singapore. He was previously Consultant Medical Oncologist and Senior Partner of the Raffles Cancer Centre at Raffles Hospital. He is also an Adjunct Clinician Scientist at the Agency for Science, Technology and Research (A*STAR) and is part of the editorial advisory board of MIMS Oncology. Dr Wong is a member of the American Society of Clinical Oncology (ASCO) as well as the European Society for Medical Oncology (ESMO) and Singapore Society of Oncology.
Wong Sian Jing is the Chief Financial Officer of the Group responsible for managing the entire spectrum of the Group’s financial, taxation and treasury functions.
Prior to joining the Group, Sian Jing was the Senior Vice President – Group Operations and Finance of Asiasons WFG Financial Limited.
Sian Jing has more than 15 years of professional experience including the provision of assurance and advisory services to clients from a wide range of industries. She has also been actively involved in capital market transactions including initial public offerings, mergers and acquisitions, cross border offerings, and other capital market transactions.
She was previously a Senior Manager of the Assurance and Business Advisory Division – Capital Markets Group of PricewaterhouseCoopers Singapore.
Dr. Christina Low is responsible for developing and executing the company’s business strategies has over 19 years of clinical experience and has also spent more than five years in senior leadership roles. She currently also helms the role of CEO and Co-founder of a health tech start-up company, Hidoc Pte Ltd.
Prior to joining SMG’s senior management team, Dr Low was a Clinical Director (Executive Health Screening) at Parkway Shenton Private Limited (a Primary Care Network Arm of Parkway Pantai Limited) where she provided medical leadership of all aspects such as utilisation management, cost containment and medical quality improvement activities. Her other leadership role was a Medical Director of Lifescan Medical Centre, a subsidiary of Singapore Medical Group Limited.
Dr Low has sat on and presided over Medical Boards and Clinical Governance committees in private sector healthcare group, including Parkway Shenton.
Arifin Ng is the General Manager of the SMG International Partners (SMG IP) and Vice-President of Singapore Medical Group (SMG). He is responsible for international marketing and business development.
Arifin has more than 10 years’ experience in the healthcare industry covering operations, marketing and business development.
Prior to joining the Group, he was the Director of Operations at International Cancer Specialists (2008 to 2011) and Senior Manager for Marketing at Parkway Group Healthcare (2001 to 2008).
Arifin holds a Master of Business Administration from the Australian National University (Australia).